Literature DB >> 23377962

Oligopeptidases B from Trypanossoma cruzi and Trypanossoma brucei inhibit inflammatory pain in mice by targeting serotoninergic receptors.

Rafaela Quintanilha Abrahão1, Adriano Cardoso Franciosi, Douglas Andrade, Luiz Juliano, Maria Aparecida Juliano, Renata Giorgi, Camila Squarzoni Dale.   

Abstract

In the present study, the antinociceptive profile of oligopeptidases B from Trypanosoma cruzi (OPTc) and Trypanosoma brucei (OPTb) were examined in mice evaluated by the acetic acid-induced writhing test. Both OPTc and OPTb injected intraperitoneally attenuated the writhing numbers in the acetic acid-induced writhing test. This effect was not dependent on the enzymatic activity, but the enzyme structure was important for this purpose. Intraperitoneal pretreatment with methysergide (5-HT serotonergic receptor antagonist) attenuated antinociceptive effect induced by both OPTc and OPTb in the writhing test. However, naloxone (opioid receptor antagonist) or yohimbine (α2-adrenergic receptor antagonist) did not affect antinociception induced by both oligopeptidases. Our results suggest that OPTc and OPTb show antinociceptive property in the writhing test. Furthermore, this antinociceptive effect may be mediated by serotonergic receptor but not opioidergic or α2-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377962     DOI: 10.1007/s10753-013-9595-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  33 in total

1.  Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters.

Authors:  R E Morty; L Troeberg; J C Powers; S Ono; J D Lonsdale-Eccles; T H Coetzer
Journal:  Biochem Pharmacol       Date:  2000-11-15       Impact factor: 5.858

2.  Protease II from Escherichia coli. Purification and characterization.

Authors:  M Pacaud; C Richaud
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

3.  A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin.

Authors:  R E Morty; L Troeberg; R N Pike; R Jones; P Nickel; J D Lonsdale-Eccles; T H Coetzer
Journal:  FEBS Lett       Date:  1998-08-21       Impact factor: 4.124

4.  Proteases from Trypanosoma brucei brucei. Purification, characterisation and interactions with host regulatory molecules.

Authors:  L Troeberg; R N Pike; R E Morty; R K Berry; T H Coetzer; J D Lonsdale-Eccles
Journal:  Eur J Biochem       Date:  1996-06-15

5.  Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray.

Authors:  T L Yaksh
Journal:  Brain Res       Date:  1979-01-05       Impact factor: 3.252

6.  Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice.

Authors:  R I Taber; D D Greenhouse; J K Rendell; S Irwin
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

7.  In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.

Authors:  C Schmauss; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  1984-01       Impact factor: 4.030

8.  Activation of oligopeptidase B from Streptomyces griseus by thiol-reacting reagents is independent of the single reactive cysteine residue.

Authors:  Hirokazu Usuki; Yoshiko Uesugi; Masaki Iwabuchi; Tadashi Hatanaka
Journal:  Biochim Biophys Acta       Date:  2009-08-07

Review 9.  Cell signalling and Trypanosoma cruzi invasion.

Authors:  Barbara A Burleigh; Aaron M Woolsey
Journal:  Cell Microbiol       Date:  2002-11       Impact factor: 3.715

10.  MEROPS: the peptidase database.

Authors:  Neil D Rawlings; Fraser R Morton; Chai Yin Kok; Jun Kong; Alan J Barrett
Journal:  Nucleic Acids Res       Date:  2007-11-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.